icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon الأربعاء 13 ربيع الأول 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الرسمية الآمنة تستخدم HTTPS

تحقق من أن الموقع يستخدم بروتوكول HTTPS

icon

مسجل لدى هيئة الحكومة الرقمية برقم :

20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 191 - 200 من 496
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients Alcon Completed Travoprost 0.004% 1 C-12-009 King Khaled Eye Specialist Hospital (Riyadh)
A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. Eli Lilly Terminated Prasugrel 3 H7T-MC-TADO King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh)
A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) Merck Serono Terminated Lutropin alfa 3b EMR200061_506 King Abdulaziz University Hospital (Jeddah)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety SPIMACO Terminated Fastulin R / Normulin N 3 (version 1.4) Aug 2011 King Fahad Medical City (Riyadh)
"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " Sanofi Terminated GLIMEPIRIDE-HOE490 3 GLIME_R_05809 King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh)
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. Servier Terminated Ivabradine 3 CL3-16257-083 King Fahad Medical City (Riyadh)
A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus Bevacizumab Therapy Roche Terminated Bevacizumab+ Capecitabine 3 MO22223 King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
A Phase 3b, open-labeled, randomized, parallel-group, multi-center study to evaluate the safety of novartis MenACWY Conjugate Vaccine when administered with routine infant Vaccinations to healthy Infants Novartis Completed Meningococcal ACWY Conjugate Vaccine 3b V59P23 King Fahad Medical City (Riyadh)
An open-Label, multicenter, expanded access study of Everolimus in Patients with advanced Nerouendocrine tumors. Novartis Completed Everolimus 3b CRAD001K24133 King Faisal Specialist Hospital and Research Center (Riyadh)
An Open-lable, Randomized, Multi center, Phase III Study to Compare the Saftey and Efficacy of TKI258 Versus Sorafenib in Patients with Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor Therapies" Novartis Completed TKI258 / Sorafenib 3 CTKI258A2302 King Faisal Specialist Hospital and Research Center (Riyadh)